News About: Pharm. Industry
Drug firms pin hopes on passage of OTC drug sales bill
Many drug makers are keeping a watch on the movement of lawmakers as the government’s plan to allow the sale of painkillers and cold medicines at convenience stores is being screened at the parliamentary committee.
...
LG Life Sciences veers into generic drug markets with Pfizer
LG Life Sciences said Tuesday that it has forged a strategic alliance with Pfizer Vitals in an effort to promote its generic business at home and abroad.
Under the deal, LG will be in charge of developing and produ...
Tylenol price to rise
Johnson & Johnson Korea has a plan to increase the prices of all Tylenol products regardless of ethical or OTC, according to Janssen Korea.
It is expected that Tylenol prices will increase by 10 to 20 percent soon...
KPMA splits over president’s nomination
A controversy is quietly brewing within the Korea Pharmaceutical Manufacturers Association ahead of its next president’s nomination on the board of directors meeting on Feb. 16.
The key member of KPMA leadership te...
‘Xalost’ ophthalmic agent goes to 17 European countries
Xalost (latanoprost) eye drop, a glaucoma drug, will be exported to 17 European countries, Taejoon Pharma announced on Monday.
Taejoon has recently received the marketing authorization for Xalost in Switzerland and...
100 billion won offered as drug rebates over 5 years
Korean drug makers have been discovered to offer nearly 100 billion won in rebates between 2006 and 2010, an antitrust regulator said Sunday.
In 2011 alone, 17 local and multinational firms were ordered to pay 14.3...
Handok, Genexine to join forces in co-development of new drugs
Handok Pharmaceutical and Genexine Co., a drug development biotech, agreed to join hands to develop biobetters and biodrugs so that they can stay competitive with its foreign rivals.
The two companies signed a memo...
Daewoong, Almirall enter into licensing agreement for new COPD treatment
Daewoong Pharmaceutical said Thursday that it has signed an exclusive licensing agreement with Spain based Almirall S.A. for marketing Amirall’s Eklira (aclidinium bromide) in Korea.
Aclidinium bromide is a novel, ...
1,606 new product licenses issued in 2011
The Korea Food and Drug Administration announced Thursday that except for oriental medicines, licenses for new products totaled 1,606, a decrease of 25 percent a year earlier.
Of the licenses, prescription drugs ac...
Winners of the 13th Korea New Drug Award
The Korea Drug Research Association, under the sponsorship of the Ministry of Health and Welfare, Ministry of Knowledge Economy and the Ministry of Education, Science and Technology, will award two Korean companies wi...
